Invesco Ltd. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,882,721
-62.3%
344,823
+11.9%
0.00%
-50.0%
Q2 2023$7,653,204
+106.0%
308,100
+24.7%
0.00%
+100.0%
Q1 2023$3,715,135
+14.2%
247,017
-10.1%
0.00%0.0%
Q4 2022$3,252,221
+406.6%
274,913
+153.8%
0.00%
Q3 2022$642,000
-56.3%
108,316
-68.7%
0.00%
Q2 2022$1,469,000
-53.3%
345,733
+4.6%
0.00%
-100.0%
Q1 2022$3,144,000
-90.0%
330,460
-80.0%
0.00%
-87.5%
Q4 2021$31,393,000
-47.5%
1,652,279
-8.1%
0.01%
-46.7%
Q3 2021$59,849,000
+37.6%
1,798,393
+60.4%
0.02%
+36.4%
Q2 2021$43,496,000
-18.0%
1,121,293
+1.9%
0.01%
-21.4%
Q1 2021$53,064,000
-42.7%
1,100,895
-38.2%
0.01%
-48.1%
Q4 2020$92,663,000
+226.5%
1,781,292
+68.0%
0.03%
+170.0%
Q3 2020$28,380,000
+4844.3%
1,060,554
+934.9%
0.01%
Q3 2018$574,000
-75.4%
102,476
-42.3%
0.00%
-100.0%
Q2 2018$2,337,000
+218.8%
177,686
+98.7%
0.00%
Q4 2017$733,000
+14560.0%
89,424
+27585.4%
0.00%
Q2 2015$5,000
-99.7%
323
-99.7%
0.00%
-100.0%
Q1 2015$1,679,000
+18.2%
108,486
+21.0%
0.00%0.0%
Q4 2014$1,421,000
+1.9%
89,681
-31.3%
0.00%0.0%
Q3 2014$1,394,000
-18.2%
130,632
-28.1%
0.00%0.0%
Q2 2014$1,705,000
+502.5%
181,574
+342.5%
0.00%
Q1 2014$283,00041,0320.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders